XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating expenses:    
Research and development $ 5,985,219 $ 4,526,252
General and administrative 1,686,814 1,356,613
Total operating expenses 7,672,033 5,882,865
Loss from operations (7,672,033) (5,882,865)
Interest and amortization of debt discount/premium (expense) income (323,006) 16,924
Net loss $ (7,995,039) $ (5,865,941)
Net loss per common share, basic and diluted $ (0.41) $ (0.31)
Weighted average common shares outstanding, basic and diluted 19,537,897 19,149,417